Zulay Zayas
Adult Health · Naples, FLNPI 1942254354
Payments from drug & device makers
Across 98 payments — averaging $23.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$482
- Inari Medical, Inc.$296
- Bayer$201
- Boston Scientific$175
- Pfizer$148
- Amgen$140
- plus $898 from 18 others
What the payments were for
- Food & beverage$2,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 25 | $482 |
| Inari Medical, Inc. | 1 | $296 |
| Bayer | 8 | $201 |
| Boston Scientific | 5 | $175 |
| Pfizer | 9 | $148 |
| Amgen | 7 | $140 |
| Alnylam Pharmaceuticals Inc. | 7 | $140 |
| Philips North America LLC | 5 | $128 |
| Johnson & Johnson | 6 | $113 |
| Boehringer Ingelheim | 6 | $102 |
| Lexicon Pharmaceuticals, Inc. | 3 | $59 |
| Medtronic | 2 | $42 |
| Scpharmaceuticals Inc. | 1 | $40 |
| Baxter Healthcare | 2 | $39 |
| AstraZeneca | 2 | $30 |
| Atricure, Inc. | 1 | $29 |
| Merck | 1 | $28 |
| Convatec Inc. | 1 | $28 |
| Impulse Dynamics (USA) Inc. | 1 | $25 |
| Terumo Medical Corporation | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Novo Nordisk | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,340 in reported general payments places this provider in the 75th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 24 | $38,775 |
| XareltoRivaroxaban | 15 | $26,249 |
| Rosuvastatin Calcium | 55 | $932 |
| Metoprolol Succinate | 29 | $572 |
| Ezetimibe | 36 | $522 |
| ClopidogrelClopidogrel Bisulfate | 24 | $504 |
| Losartan Potassium | 26 | $411 |
| Atorvastatin Calcium | 39 | $400 |
| Carvedilol | 25 | $223 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 11 | $219 |
| Metoprolol Tartrate | 19 | $171 |
| Amlodipine Besylate | 18 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $148 | $38,77524 claims |
| Johnson & JohnsonXarelto | $113 | $26,24915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,237 adult health providers in Florida.
Other adult health in Naples
- Emily GuerreroNaples$14K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.